Teststreifenfixierungsvorrichtung für Optische Messungen eines Analyten

EP3954990 Art B1 22. Februar 2023

Anmelder: Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG 🇩🇪

Details

Veröffentlichungs-Nr.
EP3954990
Aktenzeichen
EP20190454
Anmeldetag
11. August 2020
Veröffentlichung
22. Februar 2023
Erteilung
22. Februar 2023
Rechtsraum
EP
IPC
G01N33/487A61B5/00G01J3/46G01J3/52G01N21/25G01N21/84
Offizieller Volltext

Abstract

The present invention relates to a test strip fixation device - being configured to be used in a method for determining a concentration of an analyte in a bodily fluid by using a mobile device having a camera, said method comprising capturing by the camera at least one image containing at least a part of an optical test strip and at least a part of said test strip fixation device, the optical test strip having a sample of the bodily fluid applied onto a reagent test region of the optical test strip, wherein the image comprises at least a part of the reagent test region having the sample of the bodily fluid applied thereto, and wherein the image comprises at least a part of a top surface of the test strip fixation device; said test strip fixation device comprising a) an essentially planar shape; b) a cut-out portion; c) a top surface comprising a plurality of color reference fields having known reference color values, including grey reference fields locally arranged around the cut-out portion and around at least some of the non-grey color reference fields; and comprising position detection code elements; d) a bottom surface comprising a fixation element for detachable connection of the optical test strip relative to said test strip fixation device, such that the reagent test region can be aligned with the cut-out portion.

Anmelder

Firmen
Roche Diabetes Care GmbH
F. Hoffmann-La Roche AG
Land
🇩🇪 Deutschland
🇩🇪 Roche Diabetes Care

Deutsche Tochtergesellschaft des Schweizer Roche-Konzerns, entwickelt Systeme zur Blutzuckermessung und Insulinabgabe für die Betreuung von Diabetespatienten.

974 Patente in unserer Datenbank

🇨🇭 Roche

Schweizer Pharma- und Diagnostikkonzern mit Sitz in Basel, gegründet 1896. Entwickelt Arzneimittel sowie Diagnostiksysteme für Labor- und klinische Anwendungen.

9.559 Patente in unserer Datenbank

Vertreten von
Riwotzki, Karsten Roche Diabetes Care GmbH · Inhouse Mannheim, Deutschland
22
Patente gesamt
5
Fachgebiete
2
Anmelder-Länder
Zum Anwaltsprofil

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen